CCND1 and head and neck squamous cell carcinoma: In addition to gene amplification, other mechanisms likely contribute to cyclin D1 protein upregulation, as its overexpression estimated by immunohistochemistry has been documented in up to 70% of HNSCC tumors [21,22].